Literature DB >> 16120830

What predicts a good response to cognitive remediation interventions?

Alice Medalia1, Randall Richardson.   

Abstract

Cognitive remediation is a behavioral intervention designed to improve cognition in people who have suffered a decline in neuropsychological functioning. The application of cognitive remediation for people with schizophrenia has become increasingly popular. In this article we attempt to determine what factors moderate outcome in cognitive remediation. This issue is of primary concern, as the efficacy of treatments largely depends on the appropriate selection of individuals and treatment methodologies that are most likely to yield gains. Three databases were examined, dividing the samples into participants who showed or did not show a marked improvement from baseline to posttest. We examined patient, illness, and treatment factors that might affect treatment response. Whereas certain patient and treatment variables did differentiate "Improvers" from "Nonimprovers," illness factors were the least likely to influence treatment outcome. Treatment intensity, type of cognitive remediation program, and therapist qualifications were identified as key treatment variables. Patient levels of motivation for treatment and baseline sets of work habits were also important moderators. While the issue of treatment intensity appears to be especially salient, there is evidence that to some extent patient and treatment variables intertwine to produce a positive response to cognitive remediation.

Entities:  

Mesh:

Year:  2005        PMID: 16120830     DOI: 10.1093/schbul/sbi045

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  59 in total

1.  The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

Authors:  Eri Nakagami; Maanse Hoe; John S Brekke
Journal:  Schizophr Bull       Date:  2010-05-12       Impact factor: 9.306

Review 2.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

3.  Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses.

Authors:  Mario Pfammatter; Ulrich Martin Junghan; Hans Dieter Brenner
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

4.  Cognitive functioning as a predictor of response to comprehensive cognitive remediation.

Authors:  Nicole R DeTore; Kim T Mueser; Jessica A Byrd; Susan R McGurk
Journal:  J Psychiatr Res       Date:  2019-03-21       Impact factor: 4.791

5.  How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia.

Authors:  John S Brekke; Maanse Hoe; Jeffrey Long; Michael F Green
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

Review 6.  Adolescence and Alcohol: a review of the literature.

Authors:  Katrin Skala; Henriette Walter
Journal:  Neuropsychiatr       Date:  2013-07-10

7.  Individual Alpha Peak Frequency Moderates Transfer of Learning in Cognitive Remediation of Schizophrenia.

Authors:  B C Castelluccio; J G Kenney; J K Johannesen
Journal:  J Int Neuropsychol Soc       Date:  2020-01       Impact factor: 2.892

Review 8.  The role of motivation for treatment success.

Authors:  Alice Medalia; Alice Saperstein
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

9.  Schizophrenia--time to commit to policy change.

Authors:  W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff
Journal:  Schizophr Bull       Date:  2014-04       Impact factor: 9.306

Review 10.  Cognitive remediation in schizophrenia.

Authors:  Alice Medalia; Jimmy Choi
Journal:  Neuropsychol Rev       Date:  2009-05-15       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.